Innovation in the Time of COVID-19

This article from highlights the innovation at work as technological solutions to help many aspects of the pandemic are quickly coming to market and having important real-time impact.

From using artificial intelligence to track the spread of the virus to using robots in hospitals to allow families to communicate with patients; from online video chat classes with independent teachers to helping small businesses apply for relief loans, startups are on the move, shifting their technology and business models to address immediate needs and looking to capitalize on trends that will endure well past the COVID-19 pandemic.

Of course, life science innovation is at the heart of getting past COVID-19 as we hope for continued progress from clinical trials of therapies and vaccines. Early indications that Gilead’s Remdesivir helps patients with severe symptoms recover more quickly helped the S&P 500 rise almost 3% this past Friday[1].

The intensity of the global effort to deal with all aspects of the pandemic may have a long-term impact on societal advances similar to World War II, the Apollo program, the personal computer, and the internet. For as horrific as COVID-19 is, the crisis is stimulating a drive to problem solving that could bring important advances to the benefit of all.

Team Hewins, LLC (“Team Hewins”) is an SEC registered investment adviser; however, such registration does not imply a certain level of skill or training and no inference to the contrary should be made. The information contained within this letter is for informational purposes only and should not be considered investment advice or a recommendation to buy or sell any types of securities. Past performance is not a guarantee of future returns. It should not be assumed that diversification protects a portfolio from loss or that the diversification in a portfolio will produce profitable results. The opinions stated herein are as of the date of this letter and are subject to change. The information contained within this letter is compiled from sources Team Hewins believes to be reliable, but we cannot guarantee accuracy. We provide this information with the understanding that we are not engaged in rendering legal, accounting, or tax services. We recommend that all investors seek out the services of competent professionals in any of the aforementioned areas. For detailed information about our services and fees, please read our Form ADV Part 2A, which can be found at or you can call us and request a copy at (650) 620–3040.

[1] Source: Morningstar, Inc.

Originally published at on April 20, 2020.